20 (AIDX) Total Liabilities (2024 - 2026)

20's (AIDX) quarterly Total Liabilities came in at $3.0 million in Q1 2026, down 26.71% on a QoQ basis from $4.2 million in Q4 2025.

20 (AIDX) Total Liabilities (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Total Liabilities data on file, last reported at $3.0 million in Q1 2026.

Quarterly Total Liabilities changed N/A year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.2 million, up 99.94% from the prior year.
Total Liabilities retreated to $3.0 million in Q1 2026, from $4.2 million in the prior quarter.
In the past five years, Total Liabilities ranged from a high of $4.2 million in Q4 2025 to a low of $2.1 million in Q4 2024.
A 3-year average of $3.1 million and a median of $3.0 million in 2026 frame the typical range for Total Liabilities.
The widest YoY moves for Total Liabilities: up 99.94% in 2025, down 99.94% in 2025.
Tracing AIDX's Total Liabilities over 3 years: stood at $2.1 million in 2024, then jumped by 99.94% to $4.2 million in 2025, then slipped by 26.71% to $3.0 million in 2026.
The last three Total Liabilities figures came in at $3.0 million (Q1 2026), $4.2 million (Q4 2025), and $2.1 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Liabilities (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	109.22 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	23.94 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	42.96 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	45.22 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	3.14 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	3.83 Bn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	26.03 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	17.70 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	3.51 Bn
10	20	5.55 Mn	1.00 Mn	304,727.00	2.96 Mn

Download Data